2023 - Research.com Medicine in Germany Leader Award
Wolfgang H. Oertel integrates several fields in his works, including Internal medicine and Psychiatry. Wolfgang H. Oertel brings together Psychiatry and Clinical psychology to produce work in his papers. Wolfgang H. Oertel integrates Clinical psychology with Psychotherapist in his research. His study ties his expertise on Quality of life (healthcare) together with the subject of Psychotherapist. Wolfgang H. Oertel performs integrative study on Quality of life (healthcare) and Disease in his works. Disease is often connected to Parkinson's disease in his work. Parkinson's disease is closely attributed to Internal medicine in his research. By researching both Cognition and Theory of mind, he produces research that crosses academic boundaries. In his works, he conducts interdisciplinary research on Theory of mind and Cognition.
In his works, Wolfgang H. Oertel conducts interdisciplinary research on Parkinson's disease and Restless legs syndrome. He combines Restless legs syndrome and Levodopa in his studies. Wolfgang H. Oertel undertakes multidisciplinary studies into Levodopa and Pramipexole in his work. His work blends Pramipexole and Dopaminergic studies together. Wolfgang H. Oertel undertakes interdisciplinary study in the fields of Dopaminergic and Dopamine through his works. In his papers, Wolfgang H. Oertel integrates diverse fields, such as Dopamine and Parkinson's disease. By researching both Disease and Risk factor, Wolfgang H. Oertel produces research that crosses academic boundaries. His work often combines Risk factor and Disease studies. His Internal medicine study frequently involves adjacent topics like Logistic regression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Günther Deuschl;Carmen Schade-Brittinger;Paul Krack;Jens Volkmann.
The New England Journal of Medicine (2006)
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome
Jun Horiguchi;Magdolna Hornyak;Ulrich Voderholzer;Meir Kryger.
Sleep Medicine (2003)
Toward a better definition of the restless legs syndrome
Arthur S. Walters;Michael S. Aldrich;Richard Allen;Sonia Ancoli‐Israel.
Movement Disorders (1995)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Alexander Gerhard;Nicola Pavese;Gary Hotton;Federico Turkheimer.
Neurobiology of Disease (2006)
Neurostimulation for Parkinson's Disease with Early Motor Complications
W. M. M. Schuepbach;J. Rau;K. Knudsen;J. Volkmann.
The New England Journal of Medicine (2013)
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
H. Sauer;W.H. Oertel.
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Günter U Höglinger;Pamela Rizk;Marie P Muriel;Charles Duyckaerts.
Nature Neuroscience (2004)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz.
Movement Disorders (2017)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem.
Movement Disorders (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: